Gilles Grateau
Research Subjects
Gilles Grateau has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Marc Delpech
Génétique et Physiopathologie des Maladies Inflammatoires, Institut National de la Santé et de la Recherche Médicale (INSERM) EMI 00-05, Faculté de Médecine Cochin Port-Royal, 24 rue du fg St Jacques, 75014, Paris, France
5 shared publications A. Pagnier
2 shared publicationsB. Neven
2 shared publications- Catherine Dodé
Laboratoire de biochimie et génétique moléculaire, hôpital Cochin, AP–HP, Paris, France
2 shared publications E. Hacchulla
2 shared publicationsI. Kone-Paut
2 shared publications
Latest Publications
- 31 October 2013
- Published by Elsevier in Annals of Physical and Rehabilitation Medicine
- Vol. 56, e109-e110
Les douleurs chroniques dans le syndrome périodique associé à la cryopyrine : étude rétrospective française de 133 patients
- 31 October 2013
- Published by Elsevier in Annals of Physical and Rehabilitation Medicine
- Vol. 56, e109-e110
Les douleurs chroniques dans le syndrome périodique associé à la cryopyrine : étude rétrospective française de 133 patients
- 31 October 2013
- Published by Elsevier in Annals of Physical and Rehabilitation Medicine
- Vol. 56, e112
Chronic pain in cryopyrin-associated periodic syndrome: A retrospective French study in 133 patients
- 31 October 2013
- Published by Elsevier in Annals of Physical and Rehabilitation Medicine
- Vol. 56, e112
Chronic pain in cryopyrin-associated periodic syndrome: A retrospective French study in 133 patients
- 14 November 2007
- Vol. 25, S93-5
Overlap syndrome between FMF and TRAPS in a patient carrying MEFV and TNFRSF1A mutations.
Familial Mediterranean Fever (FMF) and TNF-Receptor Associated Periodic Syndrome (TRAPS) are two inheritable inflammatory disorders. They share some clinical manifestations but their treatments are different. We present here the case of an overlap syndrome of FMF and TRAPS in a patient carrying a mutation in both the MEFV and TNFRSF1A genes. A 20-year-old woman of Mediterranean origin had suffered since childhood from attacks of fever and arthritis, with skin and ophthalmic manifestations. The initial diagnosis was FMF. The symptoms responded poorly to colchicine but regressed with steroids. Genetic analysis revealed a homozygous M694V mutation in MEFV and a heterozygous R92Q mutation in TNFRSF1A. We discuss the complexity of this combined FMF-TRAPS phenotype. This case shows that mutations in MEFV and TNFRSF1A can occur together in a single patient, a condition that may modify its response to treatment. It would be interesting to evaluate the role of the R92Q mutation in TNFRSF1A in patients of Mediterranean origin with FMF unresponsive to colchicine.
- 14 November 2007
- Vol. 25, S93-5
Overlap syndrome between FMF and TRAPS in a patient carrying MEFV and TNFRSF1A mutations.
Familial Mediterranean Fever (FMF) and TNF-Receptor Associated Periodic Syndrome (TRAPS) are two inheritable inflammatory disorders. They share some clinical manifestations but their treatments are different. We present here the case of an overlap syndrome of FMF and TRAPS in a patient carrying a mutation in both the MEFV and TNFRSF1A genes. A 20-year-old woman of Mediterranean origin had suffered since childhood from attacks of fever and arthritis, with skin and ophthalmic manifestations. The initial diagnosis was FMF. The symptoms responded poorly to colchicine but regressed with steroids. Genetic analysis revealed a homozygous M694V mutation in MEFV and a heterozygous R92Q mutation in TNFRSF1A. We discuss the complexity of this combined FMF-TRAPS phenotype. This case shows that mutations in MEFV and TNFRSF1A can occur together in a single patient, a condition that may modify its response to treatment. It would be interesting to evaluate the role of the R92Q mutation in TNFRSF1A in patients of Mediterranean origin with FMF unresponsive to colchicine.
- 1 October 2004
- Published by Elsevier in La Presse Médicale
- Vol. 33 (17) , 1195-1206
Fièvres intermittentes héréditaires
- 1 October 2004
- Published by Elsevier in La Presse Médicale
- Vol. 33 (17) , 1195-1206
Fièvres intermittentes héréditaires
- Open Access
- 6 January 2004
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 43 (4) , 410-415
Clinical and genetic aspects of the hereditary periodic fever syndromes
Hereditary periodic fever syndromes are a group of diseases characterized by intermittent bouts of clinical inflammation with focal organ involvement, mainly of the abdomen, musculoskeletal system and skin. The most frequent is familial Mediterranean fever, which affects patients of Mediterranean descent all over the world. Three other types have recently been characterized clinically and genetically. A thorough diagnosis is warranted, as clinical and therapeutic management is specific for each of these diseases. The underlying mechanisms of these inflammatory diseases appear to be specific for each type, involving so far unknown proteins, and have already opened new avenues in our understanding of the inflammatory response.
- 6 January 2004
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 43 (4) , 410-415
Open AccessClinical and genetic aspects of the hereditary periodic fever syndromes
Hereditary periodic fever syndromes are a group of diseases characterized by intermittent bouts of clinical inflammation with focal organ involvement, mainly of the abdomen, musculoskeletal system and skin. The most frequent is familial Mediterranean fever, which affects patients of Mediterranean descent all over the world. Three other types have recently been characterized clinically and genetically. A thorough diagnosis is warranted, as clinical and therapeutic management is specific for each of these diseases. The underlying mechanisms of these inflammatory diseases appear to be specific for each type, involving so far unknown proteins, and have already opened new avenues in our understanding of the inflammatory response.
- 1 December 2003
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 17 (6) , 929-944
Musculoskeletal disorders in secondary amyloidosis and hereditary fevers
- 1 December 2003
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 17 (6) , 929-944
Musculoskeletal disorders in secondary amyloidosis and hereditary fevers
- 30 April 2003
- Published by Elsevier in Archives de Pédiatrie
- Vol. 10 (4) , 379-384
Fièvres périodiques : des gènes à la clinique
- 30 April 2003
- Published by Elsevier in Archives de Pédiatrie
- Vol. 10 (4) , 379-384
Fièvres périodiques : des gènes à la clinique
- 1 March 2003
- Vol. 53 (5) , 516-9
[What has become of inflammatory amyloidosis?].
Inflammation associated amyloidosis (AA amyloid) remains a severe complication of chronic inflammatory diseases, namely of rheumatoid arthritis and of juvenile arthritis. Infectious causes of AA amyloid have become uncommon. In the course of chronic inflammatory diseases, amyloid should be regularly screened by proteinuria. The proof of amyloidosis requires tissue analysis examplifying specific apple-green birefringence after staining with Congo red. When amyloidosis is progressive in the course of one chronic disease, powerful anti-inflammatory and immunosuppressive drugs can be used.
- 1 March 2003
- Vol. 53 (5) , 516-9
[What has become of inflammatory amyloidosis?].
Inflammation associated amyloidosis (AA amyloid) remains a severe complication of chronic inflammatory diseases, namely of rheumatoid arthritis and of juvenile arthritis. Infectious causes of AA amyloid have become uncommon. In the course of chronic inflammatory diseases, amyloid should be regularly screened by proteinuria. The proof of amyloidosis requires tissue analysis examplifying specific apple-green birefringence after staining with Congo red. When amyloidosis is progressive in the course of one chronic disease, powerful anti-inflammatory and immunosuppressive drugs can be used.
- 15 January 2002
- Vol. 52 (2) , 155-9
[Hereditary intermittent fevers, other than familial Mediterranean fevers].
Familial Mediterranean fever is no more the sole hereditary disease characterized by recurrent inflammatory attacks. Three other main entities have now been defined, both at clinical and genetic levels: a dominant disease due to mutations of one of the tumour necrosis factor receptor, called TRAPS for tumour necrosis factor receptor associated periodic syndrome, the hyper-immuno-globulinaemia D and periodic fever syndrome (HIDS), which is a metabolic disorder and the Muckle-Wells syndrome. A thorough diagnosis of these diseases is crucial for appropriate management and treatment.
- 15 January 2002
- Vol. 52 (2) , 155-9
[Hereditary intermittent fevers, other than familial Mediterranean fevers].
Familial Mediterranean fever is no more the sole hereditary disease characterized by recurrent inflammatory attacks. Three other main entities have now been defined, both at clinical and genetic levels: a dominant disease due to mutations of one of the tumour necrosis factor receptor, called TRAPS for tumour necrosis factor receptor associated periodic syndrome, the hyper-immuno-globulinaemia D and periodic fever syndrome (HIDS), which is a metabolic disorder and the Muckle-Wells syndrome. A thorough diagnosis of these diseases is crucial for appropriate management and treatment.
- Open Access
- 1 April 2000
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 93 (4) , 223-229
Clinical versus genetic diagnosis of familial Mediterranean fever
The diagnosis of familial Mediterranean fever (FMF) has until recently been based on clinical signs alone. Discovery of the MEFV gene has enabled a molecular approach to diagnosis, which is already well established for diagnosing typical clinical forms of FMF. We evaluated the utility of this molecular approach in a large series of patients with various clinical presentations and ethnic origins. We looked for mutations in the MEFV gene in 303 unselected consecutive patients with a variable (from high to low) clinical suspicion of FMF. Two mutations were found in 133 patients (44%). In 22 patients (7%), the clinical diagnosis of FMF was unlikely according to the Tel Hashomer clinical criteria. Our results suggest that the spectrum of FMF‐associated signs is broader than previously believed. Wider indications for genotyping should lead to more frequent diagnosis of FMF.
- 1 April 2000
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 93 (4) , 223-229
Open AccessClinical versus genetic diagnosis of familial Mediterranean fever
The diagnosis of familial Mediterranean fever (FMF) has until recently been based on clinical signs alone. Discovery of the MEFV gene has enabled a molecular approach to diagnosis, which is already well established for diagnosing typical clinical forms of FMF. We evaluated the utility of this molecular approach in a large series of patients with various clinical presentations and ethnic origins. We looked for mutations in the MEFV gene in 303 unselected consecutive patients with a variable (from high to low) clinical suspicion of FMF. Two mutations were found in 133 patients (44%). In 22 patients (7%), the clinical diagnosis of FMF was unlikely according to the Tel Hashomer clinical criteria. Our results suggest that the spectrum of FMF‐associated signs is broader than previously believed. Wider indications for genotyping should lead to more frequent diagnosis of FMF.